Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (ATTEMPT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04014803
Recruitment Status : Not yet recruiting
First Posted : July 10, 2019
Last Update Posted : October 2, 2019
Sponsor:
Collaborators:
Inje University
Seoul St. Mary's Hospital
Mediplex Sejong Hospital
Chonnam National University Hospital
Sejong General Hospital
Wonkwang University Hospital
Gachon University Gil Medical Center
Keimyung University Dongsan Medical Center
Chungbuk National University Hospital
Yeungnam University Hospital
Chungnam National University Hospital
Wonju Severance Christian Hospital
Konkuk University Chungju Hospital
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Dankook University
Incheon St.Mary's Hospital
Gyeongsang National University Hospital
Soonchunhyang University Hospital
Ewha Womans University Seoul hospital
Information provided by (Responsible Party):
Joo-Yong Hahn, Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 30, 2023
Estimated Study Completion Date : December 31, 2023